Internal Medicine, Hematology & Oncology · Brooklyn, NY
NPI
1770978231
Since 2015
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
8686 Bay Pkwy Ste M1
Brooklyn, NY, 11214
Phone (718) 372-1188
Groups this clinician bills Medicare through
Medicare paid, 2024
$29K
2,792 services
Medicare patients, 2024
21
Average age 72
Drug cost, 2024
$2.3M
1,383 prescriptions
Company payments, 2025
$1,188
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alex Wu was code 99214 (office e&m - established), 171 times for 21 patients. In total Alex Wu billed 2,792 services in 37 codes, and Medicare paid $29K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-04-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 171 | 21 | $111.07 | $19K |
| 36415 Venipuncture Blood Collection | Office | 82 | 16 | $8.65 | $709 |
| 99497 Care Management/Coordination | Office | 30 | 11 | $68.10 | $2,043 |
By year: 2022 $27K for 4,768 services; 2023 $9,084 for 1,462 services; 2024 $29K for 2,792 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 82 | 16 | $8.65 | $709 |
Medicare prescription drug claims, 2024
In 2024, the drug Alex Wu prescribed most often to Medicare patients was Metoclopramide Hcl, with 50 prescriptions and refills. In total Alex Wu wrote 1,383 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoclopramide Hcl Generic | 50 | 50 | Under 11 | $69.96 |
| Dexamethasone Sodium Phosphate Generic | 50 | 50 | Under 11 | $74.87 |
| Triamcinolone Acetonide Generic | 46 | 47 | 16 | $800 |
| Famotidine Famotidine/Pf | 45 | 45 | Under 11 | $48.18 |
| Diphenhydramine Hcl Generic | 44 | 44 | Under 11 | $67.15 |
| Folic Acid Generic | 41 | 87 | 11 | $71.2 |
| Eliquis Apixaban | 36 | 40 | Under 11 | $20K |
| Hydroxyurea Generic | 29 | 37 | Under 11 | $238 |
| Gammagard Liquid Immun Glob G(Igg)/Gly/Iga Ov50 | 27 | 27 | Under 11 | $562K |
| Amlodipine Besylate Generic | 27 | 63 | Under 11 | $211 |
| Potassium Chloride Generic | 26 | 27 | Under 11 | $142 |
| Gemcitabine Hcl Generic | 25 | 25 | Under 11 | $9,744 |
| Tagrisso Osimertinib Mesylate | 25 | 25 | Under 11 | $423K |
| Allopurinol Generic | 24 | 34 | Under 11 | $90.94 |
| Aprepitant Generic | 24 | 24 | Under 11 | $5,047 |
Brand drugs: - claims; generic drugs: 1,033 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alex Wu $1,188 ($1,188 in general payments such as food, travel and fees) from 19 companies. The largest payer was Astellas Pharma US Inc with $243.
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc 4503.T | 10 | $243 |
| Exelixis Inc. EXEL | 2 | $120 |
| Janssen Biotech, Inc. JNJ | 5 | $116 |
| Daiichi Sankyo Inc. 4568.T | 4 | $98.49 |
| Celgene Corporation BMY | 4 | $85.22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $84.24 |
| Shield Therapeutics Inc STX.L | 4 | $71 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $64.94 |
| Sobi, Inc SOBI.ST | 2 | $42.05 |
| Geron Corporation GERN | 2 | $40.5 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.